Quantcast

Latest Proteasome inhibitor Stories

2010-07-23 16:02:00

EMERYVILLE, Calif., July 23 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will host a teleconference and webcast on Monday, July 26, 2010, at 8:00 a.m. Eastern Time (5:00 a.m.

2010-07-12 14:11:11

A new study by researchers from the John Theurer Cancer Center at Hackensack University Medical Center sheds light on how bortezomib (VELCADE®), the first in a new class of cancer drugs known as proteasome inhibitors, works in mantle cell lymphoma.

2010-06-14 01:40:00

EMERYVILLE, Calif., June 14 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will host a teleconference and webcast on Monday, June 14, 2010, at 9:00 a.m. Eastern Time (6:00 a.m.

2010-06-08 15:00:00

EMERYVILLE, Calif., June 8 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at Goldman Sachs 31st Annual Global Healthcare Conference on Tuesday, June 15, 2010 at 4:55 p.m. Eastern Time (1:55 p.m. Pacific Time).

2010-06-08 08:00:00

EMERYVILLE, Calif., June 8 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc.

2010-06-05 16:30:00

EMERYVILLE, Calif., June 5 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced interim results from an ongoing Phase 2 study, known as the 004 study.

2010-06-04 14:00:00

EMERYVILLE, Calif., June 4 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc.

2010-06-01 08:00:00

EMERYVILLE, Calif., June 1 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced the initiation of a Phase 1 study of ONX 0912, an oral proteasome inhibitor, in patients with advanced refractory or recurrent solid tumors.

2010-05-20 17:01:00

EMERYVILLE, Calif., May 20 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc.

2010-02-02 07:00:00

EMERYVILLE, Calif., Feb. 2 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that the company reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 international randomized trial.


Word of the Day
inwit
  • Inward knowledge; understanding; conscience.
The word 'inwit' comes from Middle English inwit ("mind, reason, intellect, understanding; soul, spirit; feeling; the collection of inner faculties; one of five inner faculties; one of the outer bodily senses.; inward awareness of right or wrong, conscience"), from Old English *inwitt, inġewitnes ("consciousness, conscience, knowledge, knowing"), equivalent to in- +‎ wit. (Wiktionary)
Related